FF:0100093: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
|alt_id= | |alt_id= | ||
|caged_opossum_human=http://cagedop.cmmt.ubc.ca/CAGEd_oPOSSUM/results/precomputed/human/FF:0100093/results.html | |||
|comment= | |comment= | ||
|created_by= | |created_by= | ||
Latest revision as of 16:21, 18 April 2016
outline
- id: FF:0100093
- name: MCF-7 cell sample
- namespace: FANTOM5
- def: "Human breast adenocarcinoma, established from the pleural effusion of a 69-year-old caucasian woman with metastatic mammary carcinoma (after radio- and hormone therapy) in 1970; cells were described of being positive for cytoplasmic estrogen receptors and having the capability to form domes." [Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH:DSMZ]
- xref: BTO:0000093
- synonym: "MCF7 cell" RELATED []
- CAGEd oPOSSUM: human
Ontology association
Parents
| is_a: | FF:0101912(breast adenocarcinoma cell line sample) |
|---|
Children
| is a: | FF:0000426 (human MCF7 breast cancer cell line 0min after EGF1 treatment sample),FF:0000427 (human MCF7 breast cancer cell line 15min after EGF1 treatment sample),FF:0000428 (human MCF7 breast cancer cell line 30min after EGF1 treatment sample),FF:0000429 (human MCF7 breast cancer cell line 45min after EGF1 treatment sample),FF:0000430 (human MCF7 breast cancer cell line 1hr after EGF1 treatment sample),FF:0000431 (human MCF7 breast cancer cell line 80min after EGF1 treatment sample),FF:0000432 (human MCF7 breast cancer cell line 100min after EGF1 treatment sample),FF:0000433 (human MCF7 breast cancer cell line 2h after EGF1 treatment sample),FF:0000434 (human MCF7 breast cancer cell line 2.5h after EGF1 treatment sample),FF:0000435 (human MCF7 breast cancer cell line 3h after EGF1 treatment sample),FF:0000436 (human MCF7 breast cancer cell line 3.5h after EGF1 treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000438 (human MCF7 breast cancer cell line 5h after EGF1 treatment sample),FF:0000439 (human MCF7 breast cancer cell line 6h after EGF1 treatment sample),FF:0000440 (human MCF7 breast cancer cell line 7h after EGF1 treatment sample),FF:0000441 (human MCF7 breast cancer cell line 8h after EGF1 treatment sample),FF:0000442 (MCF7 breast cancer cell line 0min after HRG treatment),FF:0000443 (human MCF7 breast cancer cell line 15min after HRG treatment sample),FF:0000444 (human MCF7 breast cancer cell line 30min after HRG treatment sample),FF:0000445 (human MCF7 breast cancer cell line 45min after HRG treatment sample),FF:0000446 (human MCF7 breast cancer cell line 1hr after HRG treatment sample),FF:0000447 (human MCF7 breast cancer cell line 80min after HRG treatment sample),FF:0000448 (human MCF7 breast cancer cell line 100min after HRG treatment sample),FF:0000449 (human MCF7 breast cancer cell line 2h after HRG treatment sample),FF:0000450 (human MCF7 breast cancer cell line 2.5h after HRG treatment sample),FF:0000451 (human MCF7 breast cancer cell line 3h after HRG treatment sample),FF:0000452 (human MCF7 breast cancer cell line 3.5h after HRG treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000454 (human MCF7 breast cancer cell line 5h after HRG treatment sample),FF:0000455 (human MCF7 breast cancer cell line 6h after HRG treatment sample),FF:0000456 (human MCF7 breast cancer cell line 7h after HRG treatment sample),FF:0000457 (human MCF7 breast cancer cell line 8h after HRG treatment sample),FF:10482-107A5 (breast carcinoma cell line:MCF7) |
|---|
FF Samples
Human
- 10482-107A5 (breast carcinoma cell line:MCF7)
